BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26026064)

  • 1. A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130.
    Hong SS; Choi JH; Lee SY; Park YH; Park KY; Lee JY; Kim J; Gajulapati V; Goo JI; Singh S; Lee K; Kim YK; Im SH; Ahn SH; Rose-John S; Heo TH; Choi Y
    J Immunol; 2015 Jul; 195(1):237-45. PubMed ID: 26026064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of gp130-targeting and TNF-targeting small molecules in alleviating arthritis through the down-regulation of Th17 differentiation and osteoclastogenesis.
    Park YH; Kim HJ; Lee K; Choi Y; Heo TH
    Biochem Biophys Res Commun; 2020 Feb; 522(4):1030-1036. PubMed ID: 31818460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A directly GP130-targeting small molecule ameliorates collagen-induced arthritis (CIA) by inhibiting IL-6/GP130 signalling and Th17 differentiation.
    Park YH; Kim HJ; Heo TH
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):628-639. PubMed ID: 31742738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of LMT-28 and Metformin Improves Beneficial Anti-Inflammatory Effect in Collagen-Induced Arthritis.
    Park YH; Jang YJ; Choi Y; Lee K; Kim HJ; Cho O; Lee HR; Heo TH
    Pharmacology; 2021; 106(1-2):53-59. PubMed ID: 32674107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
    Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
    Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiinflammatory properties of a peptide derived from interleukin-4.
    Klementiev B; Enevoldsen MN; Li S; Carlsson R; Liu Y; Issazadeh-Navikas S; Bock E; Berezin V
    Cytokine; 2013 Oct; 64(1):112-21. PubMed ID: 23972727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigna angularis inhibits IL-6-induced cellular signalling and ameliorates collagen-induced arthritis.
    Oh HM; Lee SW; Yun BR; Hwang BS; Kim SN; Park CS; Jeoung SH; Kim HK; Lee WS; Rho MC
    Rheumatology (Oxford); 2014 Jan; 53(1):56-64. PubMed ID: 24097134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma.
    Zhuang PY; Wang JD; Tang ZH; Zhou XP; Quan ZW; Liu YB; Shen J
    BMC Cancer; 2015 Nov; 15():830. PubMed ID: 26525581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS.
    Kurdi M; Booz GW
    J Cell Physiol; 2007 Aug; 212(2):424-31. PubMed ID: 17385713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.
    Greenhill CJ; Rose-John S; Lissilaa R; Ferlin W; Ernst M; Hertzog PJ; Mansell A; Jenkins BJ
    J Immunol; 2011 Jan; 186(2):1199-208. PubMed ID: 21148800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
    Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
    Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin induces interleukin-6 production and activates STAT3 in adult mouse cardiac fibroblasts.
    Liao W; Yu C; Wen J; Jia W; Li G; Ke Y; Zhao S; Campell W
    Biol Cell; 2009 May; 101(5):263-72. PubMed ID: 18795895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsaicin inhibits the IL-6/STAT3 pathway by depleting intracellular gp130 pools through endoplasmic reticulum stress.
    Lee HK; Seo IA; Shin YK; Park JW; Suh DJ; Park HT
    Biochem Biophys Res Commun; 2009 May; 382(2):445-50. PubMed ID: 19285962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells.
    Sawa S; Kamimura D; Jin GH; Morikawa H; Kamon H; Nishihara M; Ishihara K; Murakami M; Hirano T
    J Exp Med; 2006 Jun; 203(6):1459-70. PubMed ID: 16717113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells.
    Kim MJ; Nam HJ; Kim HP; Han SW; Im SA; Kim TY; Oh DY; Bang YJ
    Cancer Lett; 2013 Jul; 335(1):145-52. PubMed ID: 23402820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
    Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
    J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivo.
    Yu F; Gudmundsdotter L; Akal A; Gunneriusson E; Frejd F; Nygren PÅ
    MAbs; 2014; 6(6):1598-607. PubMed ID: 25484067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.
    Ernst M; Najdovska M; Grail D; Lundgren-May T; Buchert M; Tye H; Matthews VB; Armes J; Bhathal PS; Hughes NR; Marcusson EG; Karras JG; Na S; Sedgwick JD; Hertzog PJ; Jenkins BJ
    J Clin Invest; 2008 May; 118(5):1727-38. PubMed ID: 18431520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.